These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 19392995

  • 21. Sublingual immunotherapy in the treatment of children.
    Pham-Thi N, de Blic J, Scheinmann P.
    Allergy; 2006; 61 Suppl 81():7-10. PubMed ID: 16792599
    [Abstract] [Full Text] [Related]

  • 22. Multiallergen immunotherapy for allergic rhinitis and asthma.
    Nelson HS.
    J Allergy Clin Immunol; 2009 Apr; 123(4):763-9. PubMed ID: 19217653
    [Abstract] [Full Text] [Related]

  • 23. Oral and sublingual immunotherapy: general aspects and critical considerations.
    Passalacqua G, Venturi S, Zoccali P, Braido F, Ghiazza P, Mincarini M, Canonica GW.
    Wien Med Wochenschr; 1999 Apr; 149(14-15):433-7. PubMed ID: 10584288
    [Abstract] [Full Text] [Related]

  • 24. Sublingual immunotherapy: efficacy--methodology and outcome of clinical trials.
    Malling HJ.
    Allergy; 2006 Apr; 61 Suppl 81():24-8. PubMed ID: 16792603
    [Abstract] [Full Text] [Related]

  • 25. Novel approaches in treating food allergy using allergens.
    Rancé F.
    Nestle Nutr Workshop Ser Pediatr Program; 2009 Apr; 64():157-63; discussion 164-7, 251-7. PubMed ID: 19710521
    [Abstract] [Full Text] [Related]

  • 26. How does sublingual immunotherapy work?
    Frew AJ.
    J Allergy Clin Immunol; 2007 Sep; 120(3):533-6. PubMed ID: 17765753
    [No Abstract] [Full Text] [Related]

  • 27. Physical exercise does not favour adverse reactions to allergen immunotherapy by the sublingual route.
    Senna GE, Bonadonna P, Crivellaro MA, Incorvaia C, Sensi L, Frati F, Marcucci F.
    Eur Ann Allergy Clin Immunol; 2005 Feb; 37(2):58-9. PubMed ID: 15859363
    [Abstract] [Full Text] [Related]

  • 28. Dosing of European sublingual immunotherapy maintenance solutions relative to monthly recommended dosing of subcutaneous immunotherapy.
    Larenas-Linnemann DE, Mösges R.
    Allergy Asthma Proc; 2016 Feb; 37(1):50-6. PubMed ID: 26831847
    [Abstract] [Full Text] [Related]

  • 29. Sublingual immunotherapy for Japanese cedar pollinosis.
    Okubo K, Gotoh M.
    Allergol Int; 2009 Jun; 58(2):149-54. PubMed ID: 19390236
    [Abstract] [Full Text] [Related]

  • 30. Early onset of action of a 5-grass-pollen 300-IR sublingual immunotherapy tablet evaluated in an allergen challenge chamber.
    Horak F, Zieglmayer P, Zieglmayer R, Lemell P, Devillier P, Montagut A, Mélac M, Galvain S, Jean-Alphonse S, Van Overtvelt L, Moingeon P, Le Gall M.
    J Allergy Clin Immunol; 2009 Sep; 124(3):471-7, 477.e1. PubMed ID: 19647862
    [Abstract] [Full Text] [Related]

  • 31. 'Well days' after sublingual immunotherapy with a high-dose 6-grass pollen preparation.
    Worm M.
    Allergy; 2009 Jul; 64(7):1104-5. PubMed ID: 19385951
    [No Abstract] [Full Text] [Related]

  • 32. Relationship between soluble HLA-G and HLA-A,-B,-C serum levels, and interferon-gamma production after sublingual immunotherapy in patients with allergic rhinitis.
    Ciprandi G, Continia P, Fenoglio D, Sormani MP, Negrini S, Puppo F, Indiveri F.
    Hum Immunol; 2008 Jul; 69(7):409-13. PubMed ID: 18573288
    [Abstract] [Full Text] [Related]

  • 33. Susceptibility of a grass-pollen oral immunotherapy extract to the saliva and gastric fluid digestive process.
    Igea JM, Cuevas M, Lázaro M, Quirce S, Cuesta J.
    Allergol Immunopathol (Madr); 1994 Jul; 22(2):55-9. PubMed ID: 8059676
    [Abstract] [Full Text] [Related]

  • 34. Randomized double-blind, placebo-controlled trial of sublingual immunotherapy with a Pru p 3 quantified peach extract.
    Fernández-Rivas M, Garrido Fernández S, Nadal JA, Díaz de Durana MD, García BE, González-Mancebo E, Martín S, Barber D, Rico P, Tabar AI.
    Allergy; 2009 Jun; 64(6):876-83. PubMed ID: 19183164
    [Abstract] [Full Text] [Related]

  • 35. Sublingual immunotherapy in youngsters: adherence in a randomized clinical trial.
    Röder E, Berger MY, de Groot H, Gerth van Wijk R.
    Clin Exp Allergy; 2008 Oct; 38(10):1659-67. PubMed ID: 18631346
    [Abstract] [Full Text] [Related]

  • 36. Sublingual immunotherapy: no more doubts.
    Passalacqua G, Lombardi C, Guerra L, Compalati E, Fumagalli F, Canonica GW.
    Eur Ann Allergy Clin Immunol; 2005 Oct; 37(8):314-20. PubMed ID: 17066650
    [No Abstract] [Full Text] [Related]

  • 37. Sublingual immunotherapy: from safety to mechanism of action.
    Marcucci F, Sensi L, Allocca G, Chiarello F, Palleri P, Ugolini E, Di Rienzo A, Castellani S, Incorvaia C, Di Cara G, Puccinelli P, Frati F.
    Eur Ann Allergy Clin Immunol; 2007 Mar; 39(3):101-3. PubMed ID: 17465282
    [Abstract] [Full Text] [Related]

  • 38. [Sublingual vs subcutaneous immunotherapy].
    Olivé Pérez A.
    Rev Alerg Mex; 2004 Mar; 51(1):29-35. PubMed ID: 15119753
    [Abstract] [Full Text] [Related]

  • 39. Sublingual vaccines based on wild-type recombinant allergens.
    Van Overtvelt L, Razafindratsita A, St-Lu N, Didierlaurent A, Batard T, Lombardi V, Martin E, Moingeon P.
    Eur Ann Allergy Clin Immunol; 2006 Sep; 38(7):247-9. PubMed ID: 17124785
    [Abstract] [Full Text] [Related]

  • 40. Disease-modifying effect and economic implications of sublingual immunotherapy.
    Canonica GW, Passalacqua G.
    J Allergy Clin Immunol; 2011 Jan; 127(1):44-5. PubMed ID: 21094517
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.